The future feels exciting but a little scary. We're here to help guide you through it.
How?
1. Building stronger, more abundant mindsets.
2. Shining a spotlight on the technologies of tomorrow.
3. Identifying the latest longevity & health protocols.
Health, longevity, human potential and AI.
It's great to have you here.
Julian
Site
RSS
Apple
Data updated on 03/10/2026
Recent rankings
Latest chart positions across Apple Podcasts and Spotify rankings.
Shared links between episodes and podcasts
Links found in episode descriptions and other podcasts that share them.
Ex-DeepMind Scientist WARNS: Why We Still Can’t Trust Today’s AI
Friday, October 2, 2026 • Duration 01:43:28
Is "AI is dangerous" a warning, or the world's best marketing line?
This episode is brought to you by AgelessRx, where aging becomes a puzzle that can be solved. The mission is to help you live longer and healthier by adding more life to your years through science-backed solutions and personalized care. Learn more at agelessrx.com/beyond-tomorrow.
On this episode of Beyond Tomorrow, I sit down with Thore Graepel, co-creator of AlphaGo and former researcher at Google DeepMind. I asked him straight up how close we are to superintelligence, and his answer surprised me: there won't be a single moment we can point to, and he argues human organizations like companies already count as a form of superintelligence. We get into why he thinks "AI will destroy humanity" is the biggest myth in the field, the near-term risks he does take seriously, and why I pushed him on the incentives behind the AI safety messaging coming from the labs.
From there we go deep on his core technical argument: that today's transformers are black boxes that mix knowledge and reasoning in the same weights, and that scaling alone will never make them trustworthy. He lays out a different approach built on explicit beliefs, hypotheses and evidence, and I found it one of the clearest explanations of AI transparency I've heard. In the back half, we talk about his time at Altos Labs, why biology is a reality check for the "cure all disease in 10 years" claims, and his cell annealing theory of rejuvenation.
Key Takeaways
Thore sees AI progress as a "jagged frontier," not a single superintelligence moment, and by his own definition, AGI is already here
He argues companies and institutions are already a form of superintelligence
His P(doom) is very low: extraordinary claims require extraordinary evidence, and he doesn't see it
About Thore Graepel
Thore Graepel is a computer scientist and AI researcher who recently left Google DeepMind, where he was a co-creator of AlphaGo and worked on multi-agent systems, reasoning and consciousness research. He has also spent time at Altos Labs, applying his machine learning and physics background to cellular rejuvenation, and writes about AI, reasoning and safety on Substack.
⏱ Timestamps
00:00 Intro
00:06 How Close Are We to Superintelligence?
01:42 Are Human Organizations Already Superintelligent?
02:56 Is Anyone Trying to Destroy Humanity?
04:45 Near-Term Risks: Jobs and the Economy
08:08 Why the Transition Will Be Hard
10:06 Post-AGI Planning and the Case for Positive Futures
14:35 Capability vs. Diffusion: The Train Driver Problem
16:46 Optimization vs. Game Theory
18:53 The Incentives Behind AI Safety Messaging
22:26 What Is Thore's P(doom)?
23:25 Why Transformers Are Black Boxes
29:19 How Do We Build Safer, More Transparent AI?
33:01 Separating Knowledge From Reasoning
37:39 Safety vs. Capability and the Trust Ceiling
39:45 Narrow AI vs. General AI
44:02 Do You Believe in God?
47:15 Consciousness and Whether LLMs Are Alive
51:08 AlphaGo and Move 37
58:29 Credit Assignment and Moral Reasoning
01:04:31 Who Sets the Moral Guardrails?
01:09:37 The AGI Race: US vs. China
01:11:53 Longevity and Altos Labs
01:16:01 The Biology Reality Check
01:23:04 Pockets of Computability and AlphaFold
01:26:05 Yamanaka Factors and Cell Annealing
01:35:51 Will the Singularity Happen in Your Lifetime?
Dr Mike Israetel: ‘’ALMOST EVERY American Should Be On GLP-1s, Here’s Why!’’
Thursday, September 24, 2026 • Duration 01:51:32
What if vanity was actually the smart way into a longer, healthier life?
This episode is brought to you by AgelessRx, where aging becomes a puzzle that can be solved. Their mission is to help you live longer and healthier by adding more life to your years through science-backed solutions and personalized care. Learn more at agelessrx.com/beyond-tomorrow.
On this episode of Beyond Tomorrow, Dr. Mike Israetel breaks down what's actually happening in his own bloodstream: 5mg/week of tirzepatide year-round, plus retatrutide during fat-loss phases, and why he thinks “GLP-2” is a gray-market marketing term with no basis in real receptor biology.
He walks through the non-weight-loss case for these drugs, reduced systemic and neural inflammation, better glucose control, emerging anti-cancer data, and a documented drop in addictive behaviors from gambling to alcohol to cigarettes, before getting honest about the tradeoffs: undernutrition, anhedonia, and a long-term data set that, by his own admission, will never be “complete enough” for some critics.
From there the conversation moves into gray-market peptides, why Mike separates his own risk tolerance from what he'd recommend to the public, and why there currently isn't a single peptide he'd recommend for muscle growth despite the demand. The back half covers his real thesis: that appearance, not health, is the most reliable motivator most people actually respond to and that chasing it tends to produce the same outcomes doctors have failed for decades to sell through fear.
Key Takeaways
Mike takes tirzepatide (Zepbound/Mounjaro) year-round at 5mg/week and adds retatrutide during cutting phases, both well within studied dose ranges
He argues most GLP-1 “anhedonia” is caloric-deficit anhedonia, not a direct drug effect, the same thing bodybuilders experience on any aggressive diet
New aggregate mortality data shows older adults on GLP-1s die less than those who aren't, which he says partially answers the “but will it kill you later” question
There is currently no peptide he'd recommend for muscle growth, a claim he says consistently disappoints people who ask
AI Safety Expert Roman Yampolskiy WARNS About the TWO Likely Endings with AI
Thursday, September 17, 2026 • Duration 01:02:53
What happens when the technology we build becomes smarter than the people who built it?
This episode is brought to you by AgelessRx, where aging becomes a puzzle that can be solved. The mission is to help you live longer and healthier by adding more life to your years through science-backed solutions and personalized care. Learn more at http://agelessrx.com/beyond-tomorrow
AI safety researcher Roman Yampolskiy argues the real danger isn't AI, it's building a superintelligence we can no longer control. His case: solve problems with narrow, powerful tools instead, and still get breakthroughs in medicine, science, and productivity, without that risk.
The conversation covers AGI, recursive self-improvement, the singularity, and the existential and "suffering" risks they raise, plus what mass automation could mean for work and purpose.
From international AI agreements to human longevity, one question runs through it all: can we get the benefits of advanced AI without losing control of it? Yampolskiy's answer: keep building tools, not our replacement.
Roman Yampolskiy is an AI safety researcher and professor who studies the risks and implications of artificial intelligence. His work focuses on the challenge of controlling increasingly capable AI systems and the potential consequences of superintelligence.
BT Clip: Longevity Experts: The Tipping Point That Will Trigger a Global “War on Aging” (Matt Kaeberlein, Aubrey de Grey, and Gordan Lauc)
Tuesday, September 15, 2026 • Duration 08:15
Let's get into the rapidly evolving future of longevity, from the moment society finally believes aging is solvable to the possibility of humans routinely living far beyond today’s lifespan — even approaching 150 years. Matt Kaeberlein, Aubrey de Grey, and Gordan Lauc explore how breakthroughs in aging science could also extend the lives of companion animals, while exposing how bad science and misallocated resources continue to slow meaningful progress. It’s a grounded, forward-looking discussion on what true longevity innovation requires.
Watch the full episode here: https://open.spotify.com/episode/1Rmtl7sqoFOWolXWV6O22U?si=cd176f6a28404b4d
DAVID EAGLEMAN: The END of Human Presidents is COMING. Should We Worry?
Thursday, September 10, 2026 • Duration 45:40
Could an AI actually run the country better than a person could?
This episode is brought to you by AgelessRx, where aging becomes a puzzle that can be solved. The mission is to help you live longer and healthier by adding more life to your years through science-backed solutions and personalized care. Learn more at http://agelessrx.com/beyond-tomorrow
David Eagleman doesn't shy away from the question. He lays out the case for an AI president, one that could crunch more data than any human cabinet, sidestep the ego and grudges that shape so many political decisions, and maybe even out-think our worst instincts.
Sounds great, until you ask the harder questions. Who writes the code that decides what "the greater good" means? Can a machine actually be moral, or just really good at faking it? And if an AI ever did hold real power, who's holding the leash?
We get into all of it: democracy, tribalism, consciousness, and how close we actually are to AGI. David doesn't pretend to have it all figured out but he makes a compelling case that the ground is shifting faster than most of us realize.
David Eagleman is a neuroscientist at Stanford University and an internationally bestselling author. He is co-founder of several neurotech companies, including Jojo, BrainCheck, and Neosensory, and he also directs the Center for Science and Law, a national non-profit institute. He is best known for his work on sensory substitution, time perception, brain plasticity, synesthesia, and neurolaw.
BT Clip: Harvard Geneticist: "Immortality May Have Already Happened!" (George Church)
Tuesday, September 8, 2026 • Duration 07:09
What if immortality didn’t arrive as a single breakthrough but quietly, step by step?In this clip, George Church explains the idea of “longevity escape velocity”: the point where medical progress extends life faster than we age. If each generation of therapies buys us more time to develop the next, the path to dramatically longer lives or even practical immortality may already have begun.Watch the full episode here: https://open.spotify.com/episode/0c2x5fNYLSzvvfIil3c7WK?si=854bb724225e4136
Peter Diamandis: "AGI Is Already Here - They Just Haven't Released It Yet"
Thursday, September 3, 2026 • Duration 14:26
What if the Singularity isn’t coming but already here?
This episode is brought to you by AgelessRx, where aging becomes a puzzle that can be solved. The mission is to help you live longer and healthier by adding more life to your years through science-backed solutions and personalized care. Learn more at http://agelessrx.com/beyond-tomorrow
AI is accelerating breakthroughs across science, medicine, and technology at a pace once considered impossible. Peter Diamandis believes the next 5–10 years could redefine what humanity can achieve.
Yet AI’s promise is competing with fear, disruption, and dystopian narratives. The challenge is not only building the future, but shaping how people imagine it.
For Peter Diamandis, the answer is actionable optimism: identify the risks, believe they can be solved, and pursue the biggest moonshots. Longevity, education, and space could become the foundations of a radically different future.
Peter Diamandis is an entrepreneur, physician, and founder of XPRIZE and Singularity University. He is a leading advocate for moonshot thinking and breakthrough technologies.
⏱ Timestamps
00:00 Intro
00:10 The Blinding Speed of Change
02:06 A Future Where Anything Is Possible
04:06 Why Is the West Afraid of AI?
08:39 Why Fear AI?
10:23 AGI Is Already Here
11:37 Blind Optimism vs. Actionable Optimism
BT Clip: AGI Pioneers: ChatGPT Won’t Get Us to AGI.. Here’s What Will (Ben Goertzel)
Tuesday, September 1, 2026 • Duration 09:22
Are large language models like ChatGPT and Claude enough to create AGI?In this clip, Ben Goertzel explains why today’s LLMs are incredibly powerful, but still fundamentally different from true artificial general intelligence.He argues that simply building a bigger version of ChatGPT or Claude is unlikely to produce human-level AGI. Instead, reaching AGI will require new AI architectures that can go beyond their training, generalize to unfamiliar problems and make genuinely novel leaps in reasoning.Ben also explains why current models can already outperform humans in areas like coding, mathematics and knowledge retrieval, while still struggling with the kind of imagination and general intelligence humans use to push beyond existing knowledge.
Full episode here: https://open.spotify.com/episode/7wGN1x0vQQgdzoktHipqBK?si=454702357d55415e
Ben Goertzel: Whoever Gets AGI First Can CONQUER THE PLANET
Friday, August 28, 2026 • Duration 52:19
How close are we to AGI?
This episode is brought to you by AgelessRx, where aging becomes a puzzle that can be solved. The mission is to help you live longer and healthier by adding more life to your years through science-backed solutions and personalized care. Learn more at http://agelessrx.com/beyond-tomorrow
The race toward AGI is entering a new phase. Ben Goertzel explores alternative paths to intelligence beyond simply building bigger models.
The conversation also examines the global AI race. The U.S. and China are competing for technological leadership. But the future of AI may not remain centralized.
Then comes the bigger question: what happens after superintelligence? Goertzel imagines AI that could protect humanity. It could even help overcome aging, disease, and other human limitations.
Ben Goertzel is an AI researcher, futurist, and CEO of SingularityNET and BGI Labs. Widely recognized as one of the pioneers of Artificial General Intelligence, he has spent more than two decades developing decentralized AI systems designed to benefit humanity.
What You’ll Learn
Why the AI revolution may be bigger than previous technological shifts
How AI could become an extension of human intelligence
Why agency may matter more than machine consciousness
How the brain creates a simulated model of reality
Whether consciousness could emerge on different substrates
Why AI alignment is also a problem of human alignment
How AI could help humanity become smarter and more coherent
BT Clip: MIT Professor: "We Have 18 Months Before AI Lockdown" (Ramesh Raskar)
Tuesday, August 25, 2026 • Duration 09:08
Ramesh Raskar explains how artificial intelligence is evolving and why the coming phase may be critical for its long-term impact on society. He discusses the role of economic systems in guiding responsible innovation and the importance of moving from simply using AI tools to actively participating in their development and governance.
Watch the full episode here: https://open.spotify.com/episode/5zyaecyejQCgbCQ2t2uTt5?si=faf738a4f4ea4a9d
Related Shows Based on Content Similarities
Discover shows related to The Beyond Tomorrow Podcast with Julian Issa, based on actual content similarities. Explore podcasts with similar topics, themes, and formats, backed by real data.
His core argument: use appearance as the entry point (build muscle, lose fat, sleep better) and let the longevity benefits follow, rather than trying to motivate people with 30-years-out health outcomes
Timestamps
00:00 Intro
00:10 Is GLP-1 a Bad Idea?
08:55 The Seatbelt Analogy for Drugs
10:30 The Peptide That's Not FDA-Approved Yet
11:30 Exactly What Mike Takes Every Week
13:59 Stacking Peptides: an N-of-1 Experiment
15:11 Why Mike Takes Anabolic Steroids
16:42 The Drug That Could Replace Steroids
18:48 Why Mike Takes Tirzepatide and Retatrutide
21:45 20-Year Life Extension
25:34 Mike's Full Daily Stack
30:47 The Looksmaxxing Trojan Horse
35:35 Sick Care vs. Health Care
38:14 Three Exercises You Can Do Today
40:36 Critiquing Brian Johnson's Protocol
43:31 Is There a One-Size-Fits-All Workout?
46:06 Zone 2 vs. Zone 5 Training
52:21 Why Most Biohacking Is a Waste of Money
54:01 Is HIIT Still the Rage?
57:09 Escaping Poverty, Fueling Success
01:04:53 Why People Take Extreme Measures to Look Good
